Treg stability in viral infection and autoimmunity

病毒感染和自身免疫中 Treg 的稳定性

基本信息

项目摘要

Our hypothesis is that viral infections have strong and diverging effects on different Treg populations. Our preliminary data indicate that Foxp3+ Tregs (adaptive or naturally occurring) and IL-10+ Tregs are affected by viral infections. The underlying mechanisms are proposed to be related to the modulation of APCs, in particular interferons and TLRs, resulting in strong effects on Treg activation, stability, which could be reflected in changes in the DNA methylation status ofthe Foxp3 promoter, and cytokine production, reflected in changes in the overall pattern of epigenetic markers in the genome. Clearly defining the underlying mechanisms and their precise effects will allow us not only to better understand the response of the immune system to viral infections, but to devise better strategies to induce Tregs for the treatment of chronic inflammatory disorders such as IBD, T1D and asthma. Aim 1: Do acute or chronic viral infections destabilize Foxp3 and/or IL-10 expression and Treg activity in vitro or in vivo? Using Foxp3 and IL-10 gene reporter mice, we will test our hypothesis that Foxp3 expression and IL-10 production are modulated during viral infection, and that this occurs differentially depending on whether the infection is acute (LCMV Armstrong) or chronic (LCMV Clone 13). We will compare effector functions of Tregs before, during, and after viral infections. Aim 2: How do Tregs influence the outcome of viral infections, autoimmunity, and asthma? Here we will test our hypothesis that different Treg types, in spite of their efficacy, are not comparable in terms of outcome and function in particular disease situations in vivo. Aim 3: How do viral infections affect Tregs stability and function mechanistically? Preliminary data indicate that Treg function is affected via APCs rather than a direct influence of viral infections on Tregs. In addition TLR2 appears to modulate and eventually expand and invigorate Foxp3+ Tregs. We propose that players in the innate immune system,such as DCs and TLRs, along with endogenous ligands, such as heat shock proteins (HSPs), play an important role in determining the outcome.
我们的假设是,病毒感染对不同的Treg群体具有强烈和不同的影响。我们 初步数据表明,Foxp 3 + T细胞(适应性或天然存在的)和IL-10+ T细胞受到影响, 受到病毒感染。潜在的机制被认为与APC的调节有关, 特别是干扰素和TLR,导致对Treg激活、稳定性的强烈影响,这可能是 反映在Foxp 3启动子DNA甲基化状态的变化,以及细胞因子的产生, 基因组中表观遗传标记的整体模式的变化。明确定义基础 机制及其精确的效果不仅可以让我们更好地了解免疫系统的反应, 系统的病毒感染,但设计更好的策略,以诱导THBE治疗慢性 炎症性疾病如IBD、T1 D和哮喘。 目的1:急性或慢性病毒感染是否会使Foxp 3和/或IL-10表达和Treg活性在体外不稳定 还是在体内使用Foxp 3和IL-10基因报告小鼠,我们将检验我们的假设,即Foxp 3表达和IL-10基因的表达, IL-10的产生在病毒感染过程中受到调节,这取决于是否 感染是急性的(LCMV Armstrong)或慢性的(LCMV克隆13)。我们将比较 在病毒感染之前、期间和之后进行治疗。 目的2:THBE如何影响病毒感染、自身免疫和哮喘的结局?在这里我们将测试 我们的假设是,不同类型的Treg,尽管它们的功效,在结果方面是不可比的, 并在体内特定疾病情况下发挥作用。 目的3:病毒感染如何影响THBE的稳定性和功能机制?初步数据显示 Treg功能是通过APC而不是病毒感染对Treg的直接影响来影响的。此外 TLR 2似乎调节并最终扩增和激活Foxp 3 + TcR。我们建议玩家在 先天性免疫系统,如DC和TLR,沿着内源性配体,如热休克 热休克蛋白(HSPs)在决定结果中起着重要作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Matthias G. Von Herrath其他文献

Matthias G. Von Herrath的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Matthias G. Von Herrath', 18)}}的其他基金

Treg stability in viral infection and autoimmunity
病毒感染和自身免疫中 Treg 的稳定性
  • 批准号:
    8495227
  • 财政年份:
    2013
  • 资助金额:
    $ 41.15万
  • 项目类别:
Treg stability in viral infection and autoimmunity
病毒感染和自身免疫中 Treg 的稳定性
  • 批准号:
    8377922
  • 财政年份:
    2012
  • 资助金额:
    $ 41.15万
  • 项目类别:
Specificity of CD8 cells in islets from type 1 diabetes patients
1 型糖尿病患者胰岛中 CD8 细胞的特异性
  • 批准号:
    8655830
  • 财政年份:
    2011
  • 资助金额:
    $ 41.15万
  • 项目类别:
Specificity of CD8 cells in islets from type 1 diabetes patients
1 型糖尿病患者胰岛中 CD8 细胞的特异性
  • 批准号:
    8261913
  • 财政年份:
    2011
  • 资助金额:
    $ 41.15万
  • 项目类别:
Specificity of CD8 cells in islets from type 1 diabetes patients
1 型糖尿病患者胰岛中 CD8 细胞的特异性
  • 批准号:
    8195256
  • 财政年份:
    2011
  • 资助金额:
    $ 41.15万
  • 项目类别:
Specificity, Phenotype and Function of Pancreatic CD8 T Cells in Human Type 1 Diabetes
人类 1 型糖尿病中胰腺 CD8 T 细胞的特异性、表型和功能
  • 批准号:
    9238399
  • 财政年份:
    2011
  • 资助金额:
    $ 41.15万
  • 项目类别:
Specificity of CD8 cells in islets from type 1 diabetes patients
1 型糖尿病患者胰岛中 CD8 细胞的特异性
  • 批准号:
    8451478
  • 财政年份:
    2011
  • 资助金额:
    $ 41.15万
  • 项目类别:
Specificity of CD8 cells in islets from type 1 diabetes patients
1 型糖尿病患者胰岛中 CD8 细胞的特异性
  • 批准号:
    8828063
  • 财政年份:
    2011
  • 资助金额:
    $ 41.15万
  • 项目类别:
Specificity, Phenotype and Function of Pancreatic CD8 T Cells in Human Type 1 Diabetes
人类 1 型糖尿病中胰腺 CD8 T 细胞的特异性、表型和功能
  • 批准号:
    10061526
  • 财政年份:
    2011
  • 资助金额:
    $ 41.15万
  • 项目类别:
How IL-10R blockade can resolve persistent viral infections
IL-10R 阻断如何解决持续性病毒感染
  • 批准号:
    7919813
  • 财政年份:
    2009
  • 资助金额:
    $ 41.15万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 41.15万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 41.15万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.15万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.15万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 41.15万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.15万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 41.15万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 41.15万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 41.15万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.15万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了